A Phase II Trial to Evaluate the Efficiency and Safety of Serplulimab Plus Chemotherapy as Conversion Therapy in NSCLC
Clinical trial NCT05837052 · RECRUITING
Trial details
- NCT number
- NCT05837052
- Sponsor
- Zhejiang University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-15
- Primary completion
- 2025-06-30
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.